Jump Financial, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1831577 Chicago, IL

Position in VKTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$22,621,196

+$22,178,528 QoQ

Shares Held

579,882

+4508.5% QoQ

Ownership

0.497%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#27

of 424 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. VKTX ranks #2 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	306,330	$24,288,904
2	VKTX	Viking Therapeutics, Inc. This page	579,882	$22,621,196
3	XENE	Xenon Pharmaceuticals Inc.	260,730	$15,737,662
4	CRSP	CRISPR Therapeutics AG	277,952	$15,159,500
5	BMRN	Biomarin Pharmaceutical Inc	245,390	$14,041,214
6	SRPT	Sarepta Therapeutics, Inc.	679,445	$12,209,626
7	REGN	Regeneron Pharmaceuticals, Inc.	16,242	$10,127,536
8	RARE	Ultragenyx Pharmaceutical Inc.	286,952	$9,581,327

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,621,196	579,882	+4508.5%	Shares	Defined	2026-08-13
2025-12-31	$442,668	12,583	+1723.6%	Shares	Defined	2026-02-17
2025-09-30	$18,133	690	-99.9%	Shares	Defined	2026-08-13
2025-06-30	$12,200,997	460,415	+393.1%	Shares	Defined	2026-08-13
2024-12-31	$3,757,288	93,372	+1316.0%	Shares	Defined	2025-02-13
2024-06-30	$349,547	6,594	-80.5%	Shares	Defined	2024-11-14
2023-12-31	$629,704	33,837	-81.5%	Shares	Sole	2024-10-21
2023-09-30	$2,019,577	182,437	+221.2%	Shares	Sole	2024-10-21
2022-12-31	$533,920	56,800	-5.3%	Shares	Sole	2023-02-14
2022-09-30	$163,200	60,000	+7.4%	Shares	Sole	2022-11-07
2022-03-31	$167,649	55,883	+417.4%	Shares	Sole	2022-05-12
2021-09-30	$67,824	10,800	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.